2011;107:501 8. 404. Toma M, Buller CE, Westerhout CM, et al. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. Eur Heart J. 2010;31:1701 7. 405. Widimsky P, Holmes DR Jr. How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? Eur Heart J. 2011; 32:396 403. 406. Politi L, Sgura F, Rossi R, et al. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarc- tion: major adverse cardiac events during long-term follow-up. Heart. 2010;96:662 7. 407. Vlaar PJ, Mahmoud KD, Holmes DR Jr, et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multi- vessel disease in patients presenting with ST-segment elevation myo- cardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol. 2011;58:692 703. 408. Kornowski R, Mehran R, Dangas G, et al. Prognostic impact of staged versus one-time multivessel percutaneous interventions in acute myo- cardial infarction: analysis from the HORIZONS-AMI trial. J Am Coll Cardiol. 2011;58:704 11. 409. Rathore SS, Curtis JP, Chen J, et al. Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myo- cardial infarction: national cohort study. BMJ. 2009;338:b1807. 410. Erne P, Schoenenberger AW, Burckhardt D, et al. Effects of percuta- neous coronary interventions in silent ischemia after myocar-dial infarc- tion: the SWISSI II randomized controlled trial. JAMA. 2007;297: 1985 91. 411. Madsen JK, Grande P, Saunamaki K, et al. Danish multicenter ran- domized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction. Circulation. 1997;96:748 55. 412. Hannan EL, Samadashvili Z, Walford G, et al. 